Funding for this research was provided by:
Fujian Provincial Department of Science and Technology (2018J01306, 2017Y9079)
Fujian Provincial Health & Family Planning Commissio (2016-ZQN-32)
Fujian Provincial Platform for Medical Laboratory Research, and Key Laboratory for Tumor Individualized Active Immunity (FYKFKT- 2017015)
Text and Data Mining valid from 2020-01-15
Received: 12 June 2019
Accepted: 12 December 2019
First Online: 15 January 2020
Ethics approval and consent to participate
: This retrospective study was approved by Fujian Province Cancer Hospital Institutional Review Board (no. K201427). All patients provided written informed consent prior to treatment, and all information was anonymized prior to analysis.
: Not applicable.
: The authors declare that they have no competing interests.